1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Fujifilm Holdings Corporation
  6. News
  7. Summary
    4901   JP3814000000

FUJIFILM HOLDINGS CORPORATION

(4901)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fujifilm Launches New Device TRACMOTION Aimed at Simplifying Endoscopic Lesion Extraction During the New York Society for Gastrointestinal Endoscopy 2021 Conference

12/14/2021 | 09:00am EDT

FUJIFILM Healthcare Americas Corporation is launching TRACMOTION, the company's new device for endoscopic submucosal dissection at the New York Society of Gastrointestinal Endoscopy Conference both #400, held December 16-17 at the New York Marriott Marquis Hotel Times Square. ESD is a viable alternative to piecemeal resection or invasive surgery, and is utilized for en bloc resection of large, potentially cancerous polyps or tumors in the gastrointestinal tract. Inserted through the instrument channel of an endoscope, TRACMOTION’s 360° rotatable jaws enable easy grasping and re-grasping of large lesions, which enhances a clinicians visualization, simplifies the lesion extraction process and offers the potential to reduce ESD procedure times. With TRACMOTION, an endoscopist uses simple single-hand movements to control the distal end of the product, independent of the endoscope’s movement. TRACMOTION can hold tissue during ESD without complicated locking mechanisms, demonstrating additional efficiencies when used during this advanced procedure. TRACMOTION was designed to be used with Fujifilm’s newly-launched EI-740D/S, the first dual-channel endoscope cleared by the U.S. Food and Drug Administration for use in both upper and lower gastrointestinal applications. The endoscope features two instrument channels so clinicians can perform procedures that require a range of instruments and devices, including Fujifilm’s ClutchCutter and FlushKnife. Fujifilm’s endoscopy solutions will be available for hands-on demonstration at NYSGE - the largest regional endoscopic society in the United States, with more than 300 attending members and over 200 fellows. NYSGE attendees can visit booth #400 to demo Fujifilm’s TRACMOTION, Dual-channel Endoscope, G-EYE Endoscope, and Endoscopic Ultrasound Platform.


ę S&P Capital IQ 2021
All news about FUJIFILM HOLDINGS CORPORATION
10:17aFujifilm Provides Education Advancement Opportunities for Gastroenterologists and Endos..
AQ
05/17Fujifilm Showcases New Endoscopy Innovations for the Detection, Diagnosis, and Treatmen..
AQ
05/16RAYUS Radiology Partners with Fujifilm and selects Synapse« Enterprise Information Syst..
AQ
05/16RAYUS Radiology Partners with Fujifilm and Selects Synapse« Enterprise Information Syst..
CI
05/16FUJIFILM VisualSonics Launches the New Multi-modal Vevo F2 Imaging Platform for Preclin..
AQ
05/11Fujifilm's Attributable Net Income Grows 16.5% in FY22
MT
05/02Fujifilm Selected as Platinum Partner of the National Rural Health Association
AQ
04/27Fujifilm Awarded Pacific Air Force/Navy Order from the U.S. Department of Defense and D..
AQ
04/27Fujifilm Awarded Pacific Air Force/Navy Order from the U.S. Department of Defense and D..
CI
04/26FUJIFILM Diosynth Biotechnologies Breaks Ground on Expansion of its BioProcess Innovat..
AQ
More news
Financials
Sales 2022 2 514 B 19 613 M 19 613 M
Net income 2022 187 B 1 456 M 1 456 M
Net Debt 2022 136 B 1 065 M 1 065 M
P/E ratio 2022 15,3x
Yield 2022 1,55%
Capitalization 2 855 B 22 272 M 22 272 M
EV / Sales 2022 1,19x
EV / Sales 2023 1,09x
Nbr of Employees 73 275
Free-Float 74,1%
Chart FUJIFILM HOLDINGS CORPORATION
Duration : Period :
Fujifilm Holdings Corporation Technical Analysis Chart | 4901 | JP3814000000 | MarketScreener
Technical analysis trends FUJIFILM HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 7 124,00 JPY
Average target price 9 876,92 JPY
Spread / Average Target 38,6%
EPS Revisions
Managers and Directors
Teiichi Goto President, CEO & Representative Director
Kenji Sukeno Chairman
Takashi Iwasaki Director & Chief Technology Officer
Kunitaro Kitamura Independent Outside Director
Tatsuo Kawada Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
FUJIFILM HOLDINGS CORPORATION-18.11%21 634
ABBOTT LABORATORIES-18.62%200 553
MEDTRONIC PLC2.72%142 552
BECTON, DICKINSON AND COMPANY4.27%73 051
BAXTER INTERNATIONAL INC.-13.40%37 432
HOYA CORPORATION-26.45%35 518